Aurinia Pharmaceuticals
AUPH
#5227
Rank
C$1.67 B
Marketcap
$11.71
Share price
0.60%
Change (1 day)
4.65%
Change (1 year)

Earnings for Aurinia Pharmaceuticals (AUPH)

Earnings in 2024 (TTM): -C$57.43 Million

According to Aurinia Pharmaceuticals 's latest financial reports the company's current earnings are C$0.20 Billion. In 2023 the company made an earning of -C$0.11 Billion, an increase over its 2022 earnings that were of -C$0.16 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aurinia Pharmaceuticals from 1999 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -C$57.43 Million-45.33%
2023 -C$0.11 Billion-31.8%
2022 -C$0.16 Billion-39.4%
2021 -C$0.26 Billion61.9%
2020 -C$0.16 Billion-9.73%
2019 -C$0.18 Billion92.85%
2018 -C$90.17 Million36.25%
2017 -C$66.18 Million106.29%
2016 -C$32.08 Million-15.4%
2015 -C$37.92 Million65.84%
2014 -C$22.87 Million129.82%
2013 -C$9.95 Million-26.6%
2012 -C$13.56 Million
2010 -C$7.68 Million-39.22%
2009 -C$12.63 Million-43.78%
2008 -C$22.46 Million-53.19%
2007 -C$47.99 Million42.97%
2006 -C$33.57 Million-23.03%
2005 -C$43.61 Million36.1%
2004 -C$32.04 Million172.57%
2003 -C$11.76 Million484.61%
2002 -C$2.02 Million
2000 -C$9.55 Million453.81%
1999 -C$1.73 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
C$6.98 B-11,682.06%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$7.72 Million-87.22%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$21.46 Million-64.44%๐Ÿ‡บ๐Ÿ‡ธ USA